Legal Representation
Attorney
Paul C. Llewellyn
USPTO Deadlines
Next Deadline
21 days remaining
NOA E-Mailed - SOU Required
Due Date
August 25, 2025
Extension Available
Until February 25, 2026
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 25, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 31, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 31, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 4, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 4, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 4, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 4, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 4, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 19, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 19, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 20, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of metabolic diseases; pharmaceuticals for the regulation of the endocrine system; pharmaceuticals for the treatment of cardiovascular diseases; pharmaceuticals for the treatment of hypertension
Class 042
Pharmaceutical drug development services; biomedical research services; pharmaceutical research services; consulting services in the fields of biotechnology and pharmaceutical research and development; providing information in the fields of biotechnology and pharmaceutical research; providing scientific information in the field of biotechnology and pharmaceutical research and development
Class 044
Providing medical information in the field of biotechnology and pharmaceutical research and development
Additional Information
Design Mark
The mark consists of the stylized presentation of "E-STAR BIOTECH" features a concentric swirl design created by circles of varying sizes on the left side.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ESTAR BIOTECH
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"